Carbonic Anhydrase Inhibitors

CA I

CA Ⅱ

CA IX

CA XII

CA VII

CA VI

CA VA

CA VB

CA XIII

CA XIV

Carbonic Anhydrase Inhibitors, Activators, Modulators, Degraders & Ligands

Product Name	CA	CA I	CA Ⅱ	CA IX	CA XII	CA VII	CA VI	CA VA	CA VB	CA XIII	CA XIV	Purity
Acetazolamide				CA IX								99.85%
U-104				CA IX	CA XII							99.95%
5,6-Dihydro-2H-pyran-2-one		hCA I, Ki: 8.03 μM		hCA IX, Ki: 1.35 μM
CAII-IN-12	hCA VII, Ki: 3.6 nM	hCA I, Ki: 370 nM	hCA II, Ki: 47.8 nM
Methazolamide			CA Ⅱ									99.41%
Girentuximab				CA IX								99.90%
Zonisamide			CA Ⅱ									99.95%
Brinzolamide			CA Ⅱ									99.91%
Acetazolamide sodium				CA IX								99.54%
Dorzolamide hydrochloride			CA Ⅱ									99.86%
DPI-4452				hCA IX, Kd: 0.25 nM								99.30%
Acetazolamide (Standard)				CA IX
CAIX Inhibitor S4				CA IX								99.04%
Benzolamide			CA Ⅱ									99.59%
TAS4464 hydrochloride			CA Ⅱ, IC₅₀: 0.73 μM									98.91%
Carzenide			CA Ⅱ									99.45%
Benzenesulphonamide			CA Ⅱ									99.75%
Elsulfavirine		hCA I, Ki: 52400 nM		hCA IX, Ki: 6650 nM		CA VII, Ki: 2390 nM	CA VI, Ki: 5670 nM	CA VA, Ki: 4290 nM	CA VB, Ki: 14200 nM	CA XIII, Ki: 4820 nM	CA XIV, Ki: 1960 nM	99.90%
Furagin				hCA IX, Ki: 260 nM	hCA XII, Ki: 57 nM							99.84%
2-Aminobenzenesulfonamide				CA IX								99.90%
Halazone			CA Ⅱ
Lasamide				hCA IX, Ki: 2.67 nM	hCA XII, Ki: 7.54 nM							99.98%
Enpp/Carbonic anhydrase-IN-2				CA IX, IC₅₀: 0.33 μM	CA XII, IC₅₀: 0.68 μM							98.48%
4-Chloro-3-sulfamoylbenzoic acid		hCA I, Ki: 8847 nM	hCA II, Ki: 1382 nM	hCA IX, Ki: 8976 nM								99.85%
hCAVII/IX-IN-1				hCA IX, Ki: 38.2 nM								99.84%
Zonisamide-d₄			CA Ⅱ									99.38%
Carbonic anhydrase inhibitor 2			CA Ⅱ									98.40%
hCAIX-IN-18		hCA I, IC₅₀: 3.5 nM	hCA II, IC₅₀: 9.4 nM	hCA IX, IC₅₀: 43 nM	hCA XII, IC₅₀: 8.2 nM							98.52%
GZ22-4			CA Ⅱ, Kd: 200 nM	CA IX, Kd: 0.2 nM	CA XII, Kd: 80 nM							99.37%
Fluorometholone acetate			CA Ⅱ									98.54%
Procodazole				CA IX, IC₅₀: 8.35 μM								99.73%
EMAC10101d			CA Ⅱ									99.77%
Enpp/Carbonic anhydrase-IN-1			CA Ⅱ, IC₅₀: 0.88 μM	CA IX, IC₅₀: 1.02 μM								99.57%
Acetazolamide-¹³C₂,d₃				CA IX
EGFR/CA-IX-IN-1				CA IX, IC₅₀: 63 nM
hCAII-IN-8			hCA II, IC₅₀: 0.18 μM									99.41%
hCAXII-IN-9		hCA I, Ki: 7192.6 nM	hCA II, Ki: 188.6 nM	hCA IX, Ki: >100000 nM	hCA XII, Ki: 28 nM
CAI/II-IN-13		hCA I, IC₅₀: 309.16 nM	hCA II, IC₅₀: 267.27 nM
BChE/hCA II-IN-1		hCA I, IC₅₀: 263.67 μM	hCA II, IC₅₀: 10.69 μM
hCAIX/XII-IN-5				hCA IX, Ki: 93.9 nM	hCA XII, Ki: 85.7 nM
CAXII-IN-3		hCA I, Ki: 5.3 μM	hCA II, Ki: 75 nM	hCA IX, Ki: > 10 μM	hCA XII, Ki: 53 nM
α-Glucosidase-IN-63			hCA II, Ki: 7.0 nM	hCA IX, Ki: 64.1 nM	hCA XII, Ki: 19.9 nM
hCAIX/XII-IN-6			hCA II, Ki: 2950 nM	hCA IX, Ki: 4.1 nM	hCA XII, Ki: 7.7 nM
CAIX/XII-IN-17				hCA IX, Ki: 25.1 nM	hCA XII, Ki: 35.2 nM
hCAIX-IN-6					CA XII
BChE-IN-36	hCA VB, KA: 893 nM	hCA I, KA: 266 nM	hCA II, KA: 76.9 nM
hCAII-IN-9			hCA II, IC₅₀: 1.18 μM	hCA IX, IC₅₀: 0.17 μM	hCA XII, IC₅₀: 2.99 μM
β-Glucuronidase/hCAII-IN-2			hCA II, IC₅₀: 21.77 μM
β-Glucuronidase/hCAII-IN-1			hCA II, IC₅₀: 4.91 μM
hCA-IN-1		hCA I, Ki: 159.2 nM	hCA II, Ki: 4.8 nM	hCA IX, Ki: 15.5 nM	hCA XII, Ki: 2 nM
hCAXII-IN-1				CA IX
hCAIX/XII-IN-11				hCA IX, Ki: 0.7 μM	hCA XII, Ki: 0.7 μM
Carbonic anhydrase inhibitor 14		hCA I, Ki: 1203 nM	hCA II, Ki: 99.7 nM	hCA IX, Ki: 9.4 nM	hCA XII, Ki: 27.7 nM
Carbonic anhydrase inhibitor 3			CA Ⅱ
CA Ⅱ-IN-1			hCA II, : 0.44 μM
CAII-IN-15		hCA I, IC₅₀: 430 nM	hCA II, IC₅₀: 10 nM	hCA IX, IC₅₀: 32 nM	hCA XII, IC₅₀: 19 nM
Carbonic anhydrase-IN-37	hCA VA, Ki: 9.7 nM hCA VB, Ki: 1.0 nM hCA VII, Ki: 43.8 nM	hCA I, Ki: 50.0 nM	hCA II, Ki: 73.0 nM	hCA IX, Ki: 15.0 nM	hCA XII, Ki: 24.4 nM
CAIX/XII/NAMPT-IN-1				hCA IX, Ki: 78.1 nM	hCA XII, Ki: 64.4 nM
CAIX/CAXII-IN-1			CA Ⅱ	CA IX	CA XII
Brinzolamide hydrochloride			hCA II, IC₅₀: 3.2 nM
hCAIX-IN-24				hCA IX, Ki: 32.1 nM	hCA XII, Ki: 8.1 nM
L-650719			CA Ⅱ, Ki: 10 nM
CAII-IN-14		hCA I, Ki: 6.15 nM	hCA II, Ki: 1.65 nM	hCA IX, Ki: 5.43 nM
hCAIX-IN-19				hCA IX, Ki: 6.2 nM
AChE/hCA I-IN-1		hCA I, IC₅₀: 283.3 nM	hCA II, IC₅₀: 265.9 nM
PROTAC hCAII degrader-1			hCA II, DC₅₀: 0.5 nM
hCAIX-IN-17			CA Ⅱ	CA IX	CA XII
Carbonic anhydrase/AChE-IN-1		hCA I, Ki: 24.42 nM	hCA II, Ki: 19.95 nM
CA9hu-1				CA IX
hCAIX-IN-14				hCA IX, Ki: 134.8 nM
Carbonic anhydrase inhibitor 10				CA IX
hCA/VEGFR-2-IN-5				hCA IX, IC₅₀: 40 nM	hCA XII, IC₅₀: 3.2 nM
COX-2-IN-30		hCA I, Ki: 183.4 nM	hCA II, Ki: 81.4 nM	hCA IX, Ki: 38.4 nM	hCA XII, Ki: 21.6 nM
hCAI/II-IN-10		hCA I, IC₅₀: 4.32 nM	hCA II, IC₅₀: 3.89 nM
hCAII-IN-5			hCA II, IC₅₀: 4.55 μM
hCAIX-IN-22					hCA XII, Ki: 9.7 nM
hCAII-IN-6			CA Ⅱ
AChE/CA I-IN-1		hCA I, Ki: 0.53 μM
CAII/lX-IN-1		hCA I, IC₅₀: 1.2 μM hCA I, Ki: 0.9 μM	hCA II, IC₅₀: 6.7 μM hCA II, Ki: 4.8 μM
CA IX-IN-2			CA Ⅱ, IC₅₀: 430 nM	CA IX, IC₅₀: 5.6 nM	CA XII, IC₅₀: 7.4 nM
hCA I-IN-4		hCA I, Ki: 29.94 nM	hCA II, Ki: 17.72 nM
hCAII/IX-IN-1			hCA II, Ki: 7.4 nM	hCA IX, Ki: 7 nM
DTP348				CA IX, Ki: 8.3 nM
Carbonic anhydrase activator 1	hCA I, KA: 7.8 μM hCA II, KA: >150 μM hCA VII, KA: 2.1 μM hCA VA, KA: 3.9 μM
Elsulfavirine sodium		hCA I, Ki: 52400 nM	hCA II, Ki: 12500 nM	hCA IX, Ki: 2390 nM hCA IX, Ki: 6650 nM	hCA XII, Ki: 9801 nM		CA VI, Ki: 5670 nM	CA VA, Ki: 4290 nM	CA VB, Ki: 14200 nM	CA XIII, Ki: 4820 nM	CA XIV, Ki: 1960 nM
Carbonic anhydrase inhibitor 33		hCA I, Ki: 663 nM	hCA II, Ki: 76.1 nM	hCA IX, Ki: 19.7 nM	hCA XII, Ki: 26.1 nM
HCAIX-IN-2		CA I, Ki: 2481 nM	hCA II, Ki: 456.2 nM	hCA IX, Ki: 24.6 nM	hCA XII, Ki: 45.3 nM
hA2A/hCA XII modulator 1			CA Ⅱ		CA XII
hCA I-IN-3		hCA I, IC₅₀: 4.77 nM	hCA II, IC₅₀: 9.66 nM
hCAII/XII-IN-1			CA Ⅱ, Ki: 9.4 nM		hCA XII, Ki: 8.4 nM
CAIX/CDK-2-IN-1				CA IX, IC₅₀: 0.29 μM
Thioaspirine			hCA II, Ki: 64.3 μM	hCA IX, Ki: 10.9 μM
VM4-037				CA IX
DPP IV/hCA II-IN-1		CA I, Ki: 0.2615 μM	CA Ⅱ, IC₅₀: 36.1 nM hCA II, Ki: 0.0361 μM	hCA IX, Ki: 0.1328
NCX-278		hCA I, Ki: 410 nM	hCA II, Ki: 13 nM
CAII-IN-3			bovine CA-II, IC₅₀: 13.4 μM
BAY-79-4620 Antibody				hCA IX, Kd: 3.6 nM
Anticancer agent 314				hCA IX, Ki: 27.1 nM	hCA XII, Ki: 20.9 nM
IPM-N001				hCA IX, Kd: <0.0337 nM
Carbonic anhydrase inhibitor 12			CA Ⅱ
hCAII-IN-10		hCA I, IC₅₀: 29.2 μM	hCA II, IC₅₀: 14 nM
hCAII-IN-4			hCA II, IC₅₀: 7.78 μM
Carbonic anhydrase inhibitor 9			CA Ⅱ	CA IX
hCAIX-IN-15				hCA IX, Ki: 38.8 nM
CAIX/CAXII-IN-2				hCA IX, Ki: 8.9 nM	hCA XII, Ki: 5.3 nM
CAIX/XII-IN-16		hCA I, Ki: 2361 nM		hCA IX, Ki: 10.6 nM	hCA XII, Ki: 31.8 nM
HDAC-IN-91				CA IX, Ki: 72.03 nM	CA XII, Ki: 50.76 nM
CAIX-IN-17				CA IX, IC₅₀: 61 nM
Carbonic anhydrase inhibitor 5			CA Ⅱ	CA IX	CA XII
PDGFRA/CAIX/XII-IN-1				CA IX, Ki: 93.3 nM	CA XII, Ki: 80 nM
CA IX/VEGFR-2-IN-2				CA IX, Ki: 3.1 μM
CAIX-IN-4				CA IX, IC₅₀: 0.32 μM
NYM074				hCA IX
hCAIX/XII-IN-8		hCA I, Ki: 5269 nM	hCA II, Ki: 72.0 nM	hCA IX, Ki: 8.5 nM	hCA XII, Ki: 6.7 nM
hCAIX/XII-IN-12				hCA IX, Ki: 8.2 nM	hCA XII, Ki: 5.6 nM
CA/HDAC-IN-1			hCA II, Ki: 7.4 nM		hCA XII, Ki: 7.3 nM
Carbonic anhydrase-IN-35		hCA I, Ki: 6183 nM	hCA II, Ki: 12.7 nM	hCA IX, Ki: 0.6 nM	hCA XII, Ki: 2.2 nM
hCAIX-IN-21		hCA I, Ki: 13600 nM	hCA II, Ki: 3.5 nM	hCA IX, Ki: 5.2 nM	hCA XII, Ki: 12.6 nM
Methazolamide-d₆			CA Ⅱ
STAT3/CAIX-IN-1	hCA VB, IC₅₀: 25.40 nM		hCA II, IC₅₀: 349.30 nM	CA IX, IC₅₀: 80.45 nM
CAII-IN-11		hCA I, IC₅₀: 152 nM	hCA II, IC₅₀: 2 nM	hCA IX, IC₅₀: 6 nM	hCA XII, IC₅₀: 3 nM
CA IX/VEGFR-2-IN-3			CA Ⅱ, IC₅₀: 41 nM
hCAIX-IN-10				CA IX
hCAII-IN-3			CA Ⅱ	CA IX	CA XII
hCAI/II-IN-8		hCA I, IC₅₀: 21.35 nM	hCA II, IC₅₀: 7.12 nM
hCAIX-IN-23				hCA IX, Ki: 10.4 nM	hCA XII, Ki: 8.5 nM
hCAIX/XII-IN-15		hCA I, Ki: >100 μM	hCA II, Ki: >100 μM	hCA IX, Ki: 0.42 μM	hCA XII, Ki: 4.37 μM
CA/MAO-B-IN-1	hCA VB, IC₅₀: 8.8 nM hCA VA, IC₅₀: 9.6 nM	hCA I, IC₅₀: 553.1 nM	hCA II, IC₅₀: 41.1 nM		hCA XII, IC₅₀: 196 nM							98.34%
hCA-I/hCA-II-IN-1		hCA I, Ki: 0.22 μM	hCA II, Ki: 0.33 μM
CA-II/Dkk1-IN-1			CA Ⅱ, IC₅₀: 6.90 nM
hCAIX/XII-IN-9		hCA I, Ki: 1658 nM	hCA II, Ki: 184.8 nM	hCA IX, Ki: 8.9 nM	hCA XII, Ki: 64.8 nM
ALP/Carbonic anhydrase-IN-1			CA Ⅱ, IC₅₀: 0.44 μM	CA IX, IC₅₀: 1.61 μM	CA XII, IC₅₀: 0.51 μM							99.90%
CAIX/XII-IN-18				hCA IX, Ki: 28.1 nM	hCA XII, Ki: 11.6 nM
HCAIX-IN-1		hCA I, Ki: 694.9 nM	hCA II, Ki: 126.6 nM	hCA IX, Ki: 3.3 nM	hCA XII, Ki: 9.8 nM
Dorzolamide hydrochloride (Standard)			CA Ⅱ
Carbonic anhydrase inhibitor 20		hCA I, Ki: 47.6 nM ([1])	hCA II, Ki: 36.5 nM ([1])	hCA IX, Ki: 8.3 nM ([1])	hCA XII, Ki: 2.7 nM ([1])
Carbonic anhydrase-IN-34			hCA II, IC₅₀: 0.21 μM	hCA IX, IC₅₀: 0.21 μM	hCA XII, IC₅₀: 0.88 μM
CAI-IN-6		hCA I, Ki: 902.1 nM	hCA II, Ki: 86.1 nM
hCAIX-IN-12				CA IX
CAII-IN-13		hCA I, Ki: 968.4 nM	hCA II, Ki: 65.9 nM
hCAIX/XII-IN-1				CA IX
hCAIX/XII-IN-7		hCA I, Ki: 503.7 nM	hCA II, Ki: 59 nM	hCA IX, Ki: 3.2 nM	hCA XII, Ki: 9.2 nM
CAIX/CAXII-IN-4			CA Ⅱ, Ki: 3.035 μM	CA IX, Ki: 1.324 μM	CA XII, Ki: 0.435 μM
Phenylsulfamide			hCA II, Kd: 45.50 μM hCA II, Ki: 79.60 μM									99.90%
hCAIX-IN-8				CA IX
CA-II/TNAP-IN-1			CA Ⅱ, IC₅₀: 1.25 μM
CAI/II-IN-12		hCA I, IC₅₀: 7.12 μM	hCA II, IC₅₀: 10.62 μM
Vescalagin		hCA I, Ki: 11.75 nM	hCA II, Ki: 16.23 nM
Dorzolamide-d₅			CA Ⅱ
Dealanylascamycin		hCA I, Ki: 167 nM	hCA II, Ki: 65.2 nM	hCA IX, Ki: 143 nM
L-662583			hCA II, IC₅₀: 0.7 nM
CA IX-IN-3				CA IX, IC₅₀: 0.48 nM
Carbonic anhydrase inhibitor 25		hCA I	hCA II
hCAI/II-IN-7	bovine CA, Ki: 20.57 μM	hCA I, Ki: 23 nM	hCA II, Ki: 44 nM									99.80%
hCAIX/XII-IN-14			hCA II, Ki: 9.4 nM	hCA IX, Ki: 5.6 nM	hCA XII, Ki: 6.3 nM
Carbonic anhydrase inhibitor 19		hCA I, IC₅₀: 49.1 nM	hCA II, IC₅₀: 9.4 nM	hCA IX, IC₅₀: 4.7 nM	hCA XII, IC₅₀: 6.7 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.